United States · FDA National Drug Code directory
Ultramicrosize Griseofulvin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0115-1725_1987e911-c9f4-4425-9e48-3adc3a5f92f7
- Product NDC
- 0115-1725
- Form
- TABLET, COATED
- Composition / generic term
- Ultramicrosize Griseofulvin Tablets
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140929
- Source listing expiry
- 20261231
Source-listed ingredients
- GRISEOFULVIN — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, COATED in 1 BOTTLE, PLASTIC (0115-1725-01) · 0115-1725-01
- 1000 TABLET, COATED in 1 BOTTLE, PLASTIC (0115-1725-03) · 0115-1725-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →